Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05896826

Magnetocardiography in the Accurate Identification of Myocardial Infarction

Ultra-sensitive Magnetocardiography in the Accurate Identification of Myocardial Infarction

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,841 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Accepted

Summary

Magnetocardiography (MCG) is a promising noninvasive and accurate method for detecting myocardial infarction. Although progress has been made in this area, there is a lack of studies using up-to-date examination instruments for the calibration of MCG analysis. This is a prospective single-center study aiming to build accurate analytical models of MCG to detect myocardial infarction. Myocardial infarction are diagnosed by electrocardiogram, biomarkers (high-sensitivity cardiac troponin, etc), or non-invasive imaging (cardiac magnetic resonance or single-photon-emission tomography). Myocardial infarction is also quantified by cardiac magnetic resonance or single-photon-emission tomography. Healthy volunteers and chest pain patients who will receive electrocardiogram, biomarkers (high-sensitivity cardiac troponin, etc), or non-invasive imaging (cardiac magnetic resonance or single-photon-emission tomography) examination will be enrolled in this study.

Conditions

Interventions

TypeNameDescription
DEVICEMagnetometerinspection equipment for magnetocardiography

Timeline

Start date
2023-06-01
Primary completion
2025-10-31
Completion
2026-12-01
First posted
2023-06-09
Last updated
2025-10-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05896826. Inclusion in this directory is not an endorsement.